Taylor and Francis:

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Taylor and Francis:

Dec 28, 2024, 17:33 | Science

Saurabh Zanwar: Is risk-adapted therapy ready for prime time in Multiple Myeloma?

Saurabh Zanwar, Assistant Professor at Mayo Clinic, shared on X about recent paper by him…

Dec 21, 2024, 08:42 | Science

Eric K. Singhi: Decoding clinical trial jargon

Eric K. Singhi, Assistant Professor in the Department of General Oncology at The University of…

Aug 27, 2024, 21:28 | Blog

Mushtaq Bilal: Major academic publishers' revenue and what they pay authors and reviewers

Mushtaq Bilal shared a post on X: "Major academic publishers' revenue and what they pay…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023